TWiV reviews measles in Kenya, a trial for a intranasal COVID vaccine, dengue in the Florida Keys and in Central/South America, Spain connecting government with scientists, T cell activation and viral RNA fragments persist for up to 2 years after SARS-CoV-2 infection, and durable cross-reactive and protective antibodies against avian N2 neuraminidases elicited by A(H2N2) and A(H3N2) influenza pandemics.
Hosts: Vincent Racaniello and Alan Dove
Subscribe (free): Apple Podcasts, Google Podcasts, RSS, email
Become a patron of TWiV!
Links for this episode- MicrobeTV Discord Server
- Measles in Kenya (WHO)
- Intranasal COVID vaccine trial (NIH)
- Dengue in Florida Keys (Florida Health)
- Dengue rising in Central/South America (NPR)
- Spain to connect scientists with government (Science)
- Persistence of T cells and viral RNA after SARS-CoV-2 infection (Sci Transl Med)
- Influenza pandemics induce cross-reactive antibodies against avian N2 (Nat Comm)
- Letters read on TWiV 1129
- Timestamps by Jolene. Thanks!
Alan – The first few minutes of this video by Roger Barnes Vincent – Billy & Molly: An Otter Love Story
Listener PicksFernando – A City on Mars
Intro music is by Ronald Jenkees
Send your virology questions and comments to twiv@microbe.tv